<!--https://www.openaustralia.org.au/debates/?id=2017-10-16.56.1-->
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
 <head>
  <meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
  <title>
   Therapeutic Goods Administration: 16 Oct 2017: House debates (OpenAustralia.org)
  </title>
  <meta content="Making parliament easy." name="description"/>
  <meta content="Parliament, government, House of Representatives, Senate, Senator, MP, Member of Parliament, MPs, Australia, Australian, Therapeutic Goods Administration: 16 Oct 2017" name="keywords"/>
  <meta content="5FBaCDi8kCKdo4s64NEdB5EOJDNc310SwcLLYHmEbgg=" name="verify-v1"/>
  <meta content="width=device-width; initial-scale=1.0; maximum-scale=1.0" name="viewport">
   <link href="mailto:contact@openaustralia.org" rel="author" title="Send feedback"/>
   <link href="http://www.openaustralia.org.au/" rel="home" title="Home"/>
   <link href="/" rel="start" title="Home"/>
   <!-- skin: mobile -->
   <link href="/style/default/global_non_ns4_mobile.css" rel="stylesheet" type="text/css"/>
   <link href="/style/default/mobile.css" rel="stylesheet" type="text/css"/>
   <link href="/style/default/print.css" media="print" rel="stylesheet" type="text/css"/>
   <script type="text/javascript">
    var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
   </script>
   <script type="text/javascript">
    var pageTracker = _gat._getTracker("UA-3107958-3");
pageTracker._initData();
pageTracker._trackPageview();
   </script>
  </meta>
 </head>
 <body>
  <div id="container">
   <a name="top">
   </a>
   <div id="banner">
    <div id="title">
     <h1>
      <a href="/" title="To the front page of the site">
       <img alt="OpenAustralia.org beta" height="32" src="/images/openaustraliaorgbeta.gif" width="262"/>
      </a>
     </h1>
    </div>
   </div>
   <!-- end #banner -->
   <div id="content">
    <div class="stripe-head-1">
     <div class="main">
      <h2>
       House debates
      </h2>
      <h3>
       Monday, 16 October 2017
      </h3>
      <h4>
       Statements by Members
      </h4>
      <h5>
       Therapeutic Goods Administration
      </h5>
      <p>
       1:59 pm
      </p>
      <a name="g56.2">
      </a>
      <p class="speaker">
       <a href="/mp/?m=617" title="See more information about Craig Kelly">
        <img alt="Photo of Craig Kelly" class="portrait" src="/images/mps/10750.jpg"/>
        <strong>
         Craig Kelly
        </strong>
       </a>
       <small>
        (Hughes, Liberal Party) |
        <a href="http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;adv=yes;orderBy=_fragment_number,doc_date-rev;page=0;query=Dataset%3Ahansardr,hansardr80%20Date%3A16%2F10%2F2017;rec=0;resCount=Default" title="The source of this piece of text">
         Hansard source
        </a>
        <!-- | <script type="text/javascript" src="http://parlvid.mysociety.org/video.cgi?gid=2017-10-16.56.2&output=js-link"></script> -->
       </small>
       <p>
        I would like to raise some concerns that have been expressed to me by constituents in my electorate of the
        <a href="http://en.wikipedia.org/wiki/Therapeutic_Goods_Administration" rel="nofollow">
         Therapeutic Goods Administration
        </a>
        decision to change codeine from a schedule 2 to a schedule 4 good by February 2018. This would actually require that any drug that currently contains codeine no longer be available directly from a pharmacist. It would require someone to go to their doctor to get a prescription. Now, it is true that nobody disputes that there are many risks associated with products that contain codeine. However, what we have to consider are the unintended consequences of such a ban. It will see greater pressure on Medicare and on our healthcare system, and many constituents in regional areas will have to go to their doctor and will have to pay the gap fee. So I would hope that both sides of politics here, rather than nitpick, can discuss this issue with the states and work with the Pharmacy Guild and with the medical professionals to see if we can solve this problem. We don't want the drugs sold over the counter. There is a way that the drug can be dispensed through the pharmacies with real-time monitoring, which will be just as effective but much more cost-effective than the system that is being proposed.
        <i>
         (Time expired)
        </i>
       </p>
       <a name="g56.4">
       </a>
       <p class="speaker">
        <a href="/mp/?m=680" title="See more information about Tony Smith">
         <img alt="Photo of Tony Smith" class="portrait" src="/images/mps/10592.jpg"/>
         <strong>
          Tony Smith
         </strong>
        </a>
        <small>
         (Speaker) |
         <a href="http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;adv=yes;orderBy=_fragment_number,doc_date-rev;page=0;query=Dataset%3Ahansardr,hansardr80%20Date%3A16%2F10%2F2017;rec=0;resCount=Default" title="The source of this piece of text">
          Hansard source
         </a>
         <!-- | <script type="text/javascript" src="http://parlvid.mysociety.org/video.cgi?gid=2017-10-16.56.4&output=js-link"></script> -->
        </small>
        <p>
         In accordance with standing order 43, the time for members' statements has concluded.
        </p>
        <br/>
        <br/>
        <br/>
        <br/>
        <div id="footer">
         <p>
          <a href="/?show_pc">
           View the PC OA website
          </a>
         </p>
        </div>
       </p>
      </p>
     </div>
    </div>
   </div>
  </div>
 </body>
</html>
